DYRK1A and diabetes mellitus: In addition, it was reported that EGCG could inhibit DYRK1A with an IC50 of 0.33 mM, while it exhibited low affinity for other kinases in the CMGC family, such as MAPK and GSK3β [84], indicating its distinct potential against diabetes.